rank	phenotype	cui	assoc in neigh	assoc in intom	probability	Benjamini-Hochberg	genes	
155	Azorean disease	C0024408	7	80	2.54664644928e-09	4.194857916102842e-05	CST3,AR,TTR,BBC3,GFAP,TP53,APOE
159	Neurodegenerative Diseases	C0524851	16	706	1.37348108442e-08	4.3031123139377535e-05	CST3,AR,TTR,GSN,TOMM40,SPAST,SACS,PTGS2,PKN1,GFAP,TP53,KCNMA1,AHSG,APOE,SETX,RBP4
160	Prostate cancer stage C	C0280280	5	39	1.88219068109e-08	4.330175913396482e-05	KLK3,AR,PTGS2,PKN1,TP53
161	Neuropathy ataxia retinitis pigmentosa syndrome	C0442874	10	265	2.72895496201e-08	4.35723951285521e-05	TTR,GSN,SERPING1,SACS,ALB,PTGS2,LDB3,TP53,APOE,SETX
162	Autosomal dominant non-syndromic sensorineural deafness type DFNA	C0443147	21	1262	2.90017798665e-08	4.384303112313938e-05	CST3,PLAG1,TTR,GSN,SERPING1,SPAST,KDM1A,KRT1,AP4E1,LDB3,GJC2,GFAP,TP53,CAMTA1,KCNMA1,SCN5A,KRT9,APOE,SETX,RBP4,NLRC4
165	Alzheimer Disease, Late Onset	C0494463	6	77	5.04777083465e-08	4.4654939106901214e-05	CST3,TOMM40,GFAP,APOE,RBP4,APOC1
167	Plaque, Atherosclerotic	C0011389	9	226	6.61643216882e-08	4.519621109607578e-05	CST3,TTR,GSN,SERPING1,ALB,PTGS2,PIK3R3,GFAP,APOE
173	Dermal atrophy	C0151514	9	237	1.03187206224e-07	4.682002706359946e-05	KLK3,AR,PTGS2,CRB1,TP53,APOE,PTGS1,SETX,APOC1
174	Cholecystolithiasis	C0947622	6	86	1.09059359765e-07	4.709066305818674e-05	AR,TTR,PTGS2,TP53,APOE,APOC1
176	Endometrial Hyperplasia	C0014173	5	54	1.40584540342e-07	4.7631935047361294e-05	AR,PTGS2,NCOA3,TP53,APOE
177	Motor Neuron Disease	C0085084	7	136	1.65068642421e-07	4.790257104194858e-05	AR,SPAST,HP,GFAP,TP53,APOE,SETX
178	Peripheral neuropathy, myopathy, hoarseness, and hearing loss	C0031117	15	756	2.20133370976e-07	4.817320703653586e-05	AR,TTR,GSN,SERPING1,SPAST,SACS,LDB3,GJC2,GFAP,TP53,APOE,PTGS1,SETX,TLN2,NLRC4
179	Creutzfeldt-Jakob Disease, Sporadic	C1852467	4	31	2.3754463474e-07	4.844384303112314e-05	PTGS2,GFAP,APOE,PTGS1
181	Vascular Diseases	C0042373	11	410	2.7921900958e-07	4.8985115020297695e-05	CST3,TTR,ALB,PTGS2,HP,PKN1,TP53,AHSG,APOE,PF4V1,RBP4
182	Brain Ischemia	C0007786	11	415	3.17730819543e-07	4.925575101488498e-05	CTSL,AR,TTR,ALB,PTGS2,BBC3,GFAP,TP53,SCN5A,APOE,PTGS1
183	Cognition Disorders	C0009241	5	62	3.25082640473e-07	4.952638700947226e-05	CST3,SPAST,PTGS2,APOE,APOC1
191	Prostate cancer recurrent	C0278838	4	34	3.8488862919e-07	5.16914749661705e-05	PLAG1,KLK3,AR,TP53
192	Ovarian Serous Adenocarcinoma	C1335177	5	64	3.93592580528e-07	5.196211096075778e-05	GSN,PTGS2,PKN1,TP53,KCNMA1
194	Malignant neoplasm of brain and nervous system	C0153633	7	157	4.96026146601e-07	5.2503382949932346e-05	KLK3,AR,KDM1A,PTGS2,H3F3B,GFAP,TP53
195	Invasive Lobular Breast Carcinoma	C0279565	4	36	5.17799947253e-07	5.2774018944519625e-05	AR,PTGS2,AKR1C3,TP53
196	Metastatic Carcinoma	C1384494	4	36	5.17799947253e-07	5.3044654939106904e-05	AR,GSN,TP53,CDCP1
199	Myopathy, scapulohumeroperoneal	C0026848	11	450	7.4759382529e-07	5.385656292286875e-05	CHKB,AR,TTR,ALB,PTGS2,TRAPPC11,LDB3,GFAP,OBSL1,SCN5A,APOE
204	Other disorders of the nervous system	C0027765	11	454	8.20344712937e-07	5.520974289580515e-05	CST3,AR,TTR,SPAST,SACS,PTGS2,GFAP,TP53,APOE,SCAF1,SETX
209	Alcoholic Steatohepatitis	C2718067	4	40	8.91126207492e-07	5.656292286874155e-05	BBC3,TP53,APOE,NLRC4
210	Dementia familial British	C0011265	9	302	9.56141967712e-07	5.683355886332883e-05	CST3,TTR,SPAST,ALB,PTGS2,GFAP,TP53,APOE,APOC1
212	Erythroblastosis	C0272138	4	42	1.1439735218e-06	5.7374830852503385e-05	PLAG1,KLK3,AR,GSN
213	Alzheimer Disease	C0002395	22	1699	1.21378716722e-06	5.764546684709066e-05	CST3,KLK3,CTSL,AR,TTR,SH3BP5,GSN,SERPING1,TOMM40,SPAST,ALB,PTGS2,HP,PCED1B,GFAP,TP53,KCNMA1,AHSG,APOE,PTGS1,RBP4,APOC1
214	Erythema	C0041834	6	123	1.26007030277e-06	5.791610284167794e-05	SERPING1,PTGS2,KRT1,TP53,KRT9,NLRC4
227	Abnormality of nervous system morphology	C4022810	23	1875	1.82817107919e-06	6.143437077131259e-05	CST3,CHKB,AR,TTR,GSN,SERPING1,SPAST,SACS,KDM1A,CRB1,TRAPPC11,AP4E1,LDB3,GJC2,GFAP,TP53,CAMTA1,OBSL1,SLC25A13,SCN5A,APOE,SETX,NLRC4
228	Abnormal peripheral nervous system morphology	C4025831	12	587	2.00285079321e-06	6.170500676589987e-05	CHKB,AR,TTR,GSN,SERPING1,SPAST,SACS,LDB3,GJC2,TP53,SETX,NLRC4
230	Anaplastic Oligodendroglioma	C0334590	6	135	2.35145928462e-06	6.224627875507443e-05	HIST1H3J,TSC22D1,PTGS2,GFAP,TP53,CAMTA1
231	Papilloma	C0030354	7	196	2.63311480619e-06	6.25169147496617e-05	TTR,PTGS2,KRT1,TP53,KRT9,APOE,PEG3
232	Cerebral Amyloid Angiopathy	C0085220	4	50	2.77022212536e-06	6.278755074424899e-05	CST3,TTR,GSN,APOE
239	Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract	C0152025	5	90	2.97772963698e-06	6.468200270635995e-05	TTR,GSN,ALB,LDB3,SETX
240	Aural atresia, congenital	C1842937	4	51	3.06060813049e-06	6.495263870094723e-05	CST3,TTR,GSN,APOE
241	Mild cognitive impairment	C1270972	6	141	3.14104287802e-06	6.52232746955345e-05	CST3,TTR,TOMM40,GFAP,TP53,APOE
242	Prostatic Intraepithelial Neoplasias	C0282612	6	142	3.2919784767e-06	6.549391069012179e-05	PLAG1,KLK3,AR,PTGS2,TP53,CLCA2
243	Guillain-Barre syndrome, familial	C0018378	4	52	3.37430438702e-06	6.576454668470906e-05	SERPING1,ALB,GFAP,APOE
244	Diabetic Nephropathies	C0011881	12	616	3.39214703671e-06	6.603518267929636e-05	CST3,TSC22D1,ALB,PTGS2,HP,SLC22A6,TP53,AHSG,APOE,PTGS1,RBP4,APOC1
245	Neoplasm of the liver	C0023903	18	1290	3.56599225471e-06	6.630581867388363e-05	AR,TTR,SERPING1,SLC1A5,ALB,DCD,KDM1A,PTGS2,HP,ITIH1,BBC3,PKN1,TP53,SLC25A13,AHSG,HPX,APOE,RBP4
248	Cervical Adenocarcinoma	C0279672	4	53	3.71272798871e-06	6.711772665764547e-05	KLK3,PTGS2,TP53,PTGS1
249	Inclusion Body Myopathy, Sporadic	C0751713	4	53	3.71272798871e-06	6.738836265223275e-05	CST3,TTR,TOMM40,APOE
250	Cerebral palsy, spastic quadriplegic, 3	C0007789	5	95	4.08296258958e-06	6.765899864682003e-05	CTSL,TTR,PTGS2,AP4E1,APOE
251	Disorders of Sex Development	C0036875	3	25	4.23610025035e-06	6.79296346414073e-05	KLK3,AR,AKR1C3
252	Diabetes mellitus type 2	C0011860	23	1972	4.37963836841e-06	6.820027063599459e-05	CST3,DGKG,CTSL,AR,TTR,GSN,TOMM40,THRAP3,TSC22D1,ALB,DCD,PTGS2,CRB1,HP,TP53,CAMTA1,AHSG,SCN5A,HPX,APOE,PEG3,RBP4,APOC1
261	Aicardi Goutieres syndrome 1	C0796126	4	56	4.89020563788e-06	7.06359945872801e-05	CST3,PTGS2,BBC3,TP53
262	{Aneurysm, familial abdominal 3} (2)	C0002940	6	151	4.94401612861e-06	7.090663058186739e-05	CST3,PTGS2,HP,TP53,SLA2,APOE
263	Ischemia	C0022116	12	647	5.76718846101e-06	7.117726657645466e-05	AR,TTR,SLC1A5,ALB,PTGS2,PKN1,PIK3R3,GFAP,TP53,KCNMA1,SCN5A,APOE
264	Coronary heart disease 7	C0010054	13	754	6.07547484033e-06	7.144790257104195e-05	CST3,AR,ALB,PTGS2,HP,TP53,AHSG,SCN5A,APOE,PF4V1,PTGS1,RBP4,APOC1
265	Kidney Diseases	C0022658	13	755	6.16763477013e-06	7.171853856562922e-05	CST3,CTSL,AR,TTR,GSN,ALB,PTGS2,HP,SLC22A6,TP53,AHSG,APOE,RBP4
266	Abnormality of metabolism/homeostasis	C4021768	20	1607	6.61048673056e-06	7.198917456021652e-05	CST3,CHKB,AR,TTR,GSN,SERPING1,ALB,CRB1,TRAPPC11,KRT1,LDB3,GJC2,TP53,CAMTA1,SLC25A13,SCN5A,KRT9,APOE,SETX,NLRC4
267	Epidermolysis bullosa simplex, Cockayne-Touraine type	C0079298	3	28	6.78672666521e-06	7.225981055480379e-05	KRT1,GFAP,KRT9
268	Hereditary pancreatitis	C0238339	9	377	6.87865910676e-06	7.253044654939108e-05	PLAG1,KLK3,TSC22D1,ALB,PTGS2,HP,PRSS3,TP53,APOE
276	Adenocarcinoma of prostate	C0007112	6	161	7.53658843911e-06	7.469553450608931e-05	PLAG1,KLK3,AR,PTGS2,AKR1C3,TP53
277	Progressive Neoplastic Disease	C0677932	6	161	7.53658843911e-06	7.496617050067659e-05	KLK3,AR,TTR,PTGS2,TP53,APOE
278	Progressive cGVHD	C3539781	6	161	7.53658843911e-06	7.523680649526388e-05	KLK3,AR,TTR,PTGS2,TP53,APOE
279	Albuminuria	C0001925	6	163	8.17113213314e-06	7.550744248985115e-05	CST3,CTSL,ALB,PTGS2,HP,APOE
280	Dementia	C0497327	10	477	8.81729255087e-06	7.577807848443844e-05	CST3,TTR,SLC9A8,SPAST,ALB,PTGS2,GFAP,TP53,APOE,APOC1
281	Verrucae	C0043037	3	30	9.0220932959e-06	7.604871447902571e-05	KRT1,TP53,KRT9
282	Mixed Salivary Gland Tumor	C0026277	5	109	9.04882663577e-06	7.6319350473613e-05	PLAG1,AR,PTGS2,GFAP,TP53
283	Animal Mammary Neoplasms	C0024667	25	2352	9.17933471922e-06	7.658998646820027e-05	CST3,KLK3,CTSL,AR,GSN,SLC1A5,TSC22D1,KDM1A,PTGS2,HP,AKR1C3,ITIH1,NCOA3,HIST4H4,H3F3B,PKN1,TP53,KCNMA1,CDCP1,AHSG,SCN5A,APOE,PTGS1,RBP4,CLCA2
284	gliosarcoma	C0206726	4	64	9.49077906676e-06	7.686062246278755e-05	PTGS2,GFAP,TP53,PTGS1
287	Myocardial Infarction	C0027051	15	1019	1.04437596304e-05	7.767253044654938e-05	CST3,AR,GSN,SERPING1,PTGS2,HP,GFAP,TP53,KCNMA1,CDCP1,AHSG,SCN5A,APOE,PTGS1,APOC1
288	Cholelithiasis	C0008350	6	171	1.11703886e-05	7.794316644113668e-05	AR,TTR,PTGS2,TP53,APOE,APOC1
289	Pleomorphic adenoma of salivary gland	C1519176	3	32	1.17582773626e-05	7.821380243572395e-05	PLAG1,KLK3,AR
290	Influenza	C0021400	10	497	1.29332484315e-05	7.848443843031124e-05	TTR,SERPING1,ALB,PTGS2,HP,TP53,SLA2,PTGS1,SETX,NLRC4
291	Prostate Cancer, Hereditary, 7	C1853195	3	33	1.33346207484e-05	7.875507442489851e-05	KLK3,AR,TP53
292	Prostatitis	C0497496	3	33	1.33346207484e-05	7.90257104194858e-05	KLK3,AR,PTGS2
299	Peripheral axonal neuropathy	C1263857	4	69	1.37461803805e-05	8.092016238159675e-05	TTR,SERPING1,GJC2,SETX
300	Inclusion Body Myositis (disorder)	C0238190	4	69	1.37461803805e-05	8.119079837618404e-05	CST3,TTR,GSN,APOE
301	Amyotrophic Lateral Sclerosis	C0002736	13	812	1.39841475065e-05	8.146143437077132e-05	CST3,AR,TTR,PDZRN4,SPAST,PTGS2,PKN1,GFAP,TP53,KCNMA1,APOE,SETX,RBP4
302	Pericardial effusion	C0031039	3	34	1.50612110603e-05	8.17320703653586e-05	ALB,PTGS2,TP53
303	keratoacanthoma	C0022572	3	34	1.50612110603e-05	8.200270635994588e-05	PTGS2,TP53,PTGS1
304	Malignant neoplasm of oropharynx	C0153382	3	34	1.50612110603e-05	8.227334235453315e-05	BBC3,TP53,PEG3
305	Multiple Endocrine Neoplasia Type 2a	C0025268	4	71	1.58137722621e-05	8.254397834912044e-05	AR,HP,TP53,SCN5A
306	Impaired vibratory sensation	C1295585	3	35	1.69469045769e-05	8.281461434370771e-05	SPAST,SACS,SETX
315	Memory impairment	C0233794	7	255	1.80346276305e-05	8.525033829499324e-05	AR,SPAST,GFAP,CAMTA1,APOE,PTGS1,APOC1
316	Hypoxia	C0003130	8	335	1.82793242979e-05	8.552097428958051e-05	AR,DCD,PTGS2,HP,TP53,KCNMA1,SCN5A,APOE
317	Kidney Failure, Chronic	C0022661	11	616	1.8316137238e-05	8.57916102841678e-05	CST3,KLK3,TTR,GSN,ALB,PTGS2,HP,TP53,AHSG,APOE,PTGS1
318	Urticaria	C0042109	5	124	1.89129510627e-05	8.606224627875507e-05	SERPING1,ALB,PTGS2,PKN1,NLRC4
319	Complete trisomy 18 syndrome	C0152096	3	36	1.90004975039e-05	8.633288227334236e-05	TTR,TP53,KCNMA1
320	Chronic Kidney Insufficiency	C0403447	6	186	1.92555225453e-05	8.660351826792964e-05	CST3,ALB,HP,TP53,AHSG,APOE
408	Senile plaques	C0333463	7	259	2.01656711359e-05	0.0001104194857916103	TTR,SERPING1,ALB,PTGS2,PIK3R3,GFAP,APOE
409	Hepatic steatosis	C0015695	9	427	2.01795342288e-05	0.00011069012178619757	ALB,PTGS2,HP,NCOA3,SLC25A13,AHSG,APOE,RBP4,APOC1
410	Complications of Diabetes Mellitus	C0342257	4	75	2.06711365954e-05	0.00011096075778078485	ALB,PTGS2,HP,APOE
411	Spastic	C0443306	3	37	2.12313161203e-05	0.00011123139377537212	SPAST,GJC2,APOE
412	Corneal Diseases	C0010034	3	37	2.12313161203e-05	0.00011150202976995941	GSN,GFAP,APOE
413	Cancer of Head and Neck	C0278996	9	430	2.14221405094e-05	0.00011177266576454668	PLAG1,KLK3,AR,TTR,PTGS2,HP,BBC3,TP53,RBP4
414	Chronic kidney disease	C1561643	8	342	2.15103009793e-05	0.00011204330175913397	CST3,TOMM40,ALB,HP,TP53,AHSG,APOE,PTGS1
415	Carcinoma breast stage IV	C0278488	8	342	2.15103009793e-05	0.00011231393775372124	AR,ALB,PTGS2,HP,KRT1,TP53,KCNMA1,SCN5A
416	Adult onset ataxia with oculomotor apraxia	C1853562	5	127	2.16609962351e-05	0.00011258457374830853	AR,TTR,GSN,LDB3,APOE
417	Well Differentiated Oligodendroglioma	C0751396	6	191	2.28385118157e-05	0.0001128552097428958	HIST1H3J,TSC22D1,PTGS2,GFAP,TP53,CAMTA1
422	Mental deterioration	C0234985	6	192	2.36171838117e-05	0.00011420838971583221	CST3,TTR,TOMM40,SPAST,APOE,APOC1
423	Amyloidosis	C0002726	5	129	2.36652754271e-05	0.00011447902571041948	CST3,TTR,GSN,HP,APOE
424	Dysmetria	C0234162	4	78	2.50197418515e-05	0.00011474966170500677	SACS,GJC2,CAMTA1,SETX
425	Abnormality of circulating enzyme level	C4023591	6	194	2.52403868409e-05	0.00011502029769959404	CHKB,AR,TRAPPC11,LDB3,SCN5A,SETX
426	Subarachnoid hemorrhage	C0038525	7	268	2.57439877223e-05	0.00011529093369418133	TTR,HP,GFAP,TP53,CAMTA1,SLA2,APOE
427	Elevated serum creatine phosphokinase	C0241005	6	195	2.60857514971e-05	0.0001155615696887686	CHKB,AR,TRAPPC11,LDB3,SCN5A,SETX
428	Diabetic Retinopathy	C0011884	7	270	2.71449909757e-05	0.00011583220568335588	AR,ALB,KDM1A,PTGS2,HP,APOE,RBP4
429	Acute kidney injury	C0022660	7	270	2.71449909757e-05	0.00011610284167794317	CST3,ALB,PTGS2,HP,SLC22A6,TP53,APOE
430	Drug-Induced Liver Injury	C0860207	6	198	2.87632023869e-05	0.00011637347767253046	TTR,GSN,ALB,PTGS2,HPX,APOE
431	Prostatic Diseases	C0033575	3	40	2.90807630089e-05	0.00011664411366711773	PLAG1,KLK3,AR
432	Depressive Disorder	C0011581	10	543	2.91987282077e-05	0.00011691474966170501	AR,TTR,TOMM40,ALB,KDM1A,PTGS2,HP,TP53,APOE,PTGS1
433	 {Aerodigestive tract cancer, squamous cell, alcohol-related, protection against} (3)	C0751688	5	134	2.93352543785e-05	0.00011718538565629228	CTSL,AR,PTGS2,TP53,CDCP1
437	Hormone refractory prostate cancer	C1328504	4	81	3.00477677894e-05	0.0001182679296346414	PLAG1,KLK3,AR,TP53
438	Left ventricular hypertrophy	C0149721	7	274	3.01392774283e-05	0.00011853856562922869	CST3,CROT,AR,TTR,PTGS2,SCN5A,APOE
439	Abnormality of circulating protein level	C4023679	7	274	3.01392774283e-05	0.00011880920162381597	CHKB,AR,ALB,TRAPPC11,LDB3,SCN5A,SETX
440	Glioblastoma	C0017636	19	1645	3.20424439235e-05	0.00011907983761840326	CST3,HIST1H3J,CTSL,AR,GSN,SPAST,PTGS2,HP,CNOT1,BBC3,H3F3B,PKN1,GFAP,TP53,CAMTA1,AHSG,APOE,PTGS1,RBP4
441	Bronchogenic Carcinoma	C0007121	3	41	3.21153365039e-05	0.00011935047361299053	ALB,PTGS2,TP53
442	Pancreatitis	C0030305	7	277	3.25623078046e-05	0.00011962110960757781	CTSL,ALB,PTGS2,NCOA3,TP53,SLC25A13,APOE
443	Anaplastic astrocytoma	C0334579	5	137	3.32298990501e-05	0.00011989174560216509	TSC22D1,H3F3B,GFAP,TP53,SETX
444	Dementia, Vascular	C0011269	4	83	3.38125257846e-05	0.00012016238159675237	CST3,ALB,TP53,APOE
445	Adult type dermatomyositis	C0221056	4	83	3.38125257846e-05	0.00012043301759133964	CTSL,PTGS2,TP53,PTGS1
446	Cardiomyopathy, Dilated	C0007193	9	454	3.39594791969e-05	0.00012070365358592693	CTSL,CHKB,AR,LDB3,GFAP,TP53,SCN5A,KRT9,APOE
447	Gestational trophoblastic disease	C1135868	3	42	3.53754533058e-05	0.0001209742895805142	PKN1,TP53,PEG3
448	Chemical Carcinogenesis	C0596321	3	42	3.53754533058e-05	0.00012124492557510149	GSN,PTGS2,TP53
449	Primary malignant neoplasm of brain	C0750979	3	42	3.53754533058e-05	0.00012151556156968876	AR,KDM1A,TP53
450	{Unipolar depression, susceptibility to}, 608516 (3)	C0011570	10	555	3.56137427486e-05	0.00012178619756427606	AR,TTR,TOMM40,KDM1A,PTGS2,HP,TP53,SCN5A,APOE,PTGS1
451	Nasopharyngeal Neoplasms	C0027439	4	84	3.58267992971e-05	0.00012205683355886333	SACS,PTGS2,HP,TP53
452	Non-Hodgkin lymphoma	C0024305	10	556	3.61993902828e-05	0.00012232746955345063	KLK3,AR,SERPING1,PTGS2,HP,AKR1C3,NCOA3,TP53,APOE,PTGS1
461	Mammary Neoplasms, Experimental	C0024668	6	207	3.81861984374e-05	0.00012476319350473614	GSN,TSC22D1,PTGS2,H3F3B,TP53,RBP4
462	Anaphylactic shock NOS	C0002792	3	43	3.88713826609e-05	0.0001250338294993234	PTGS2,HP,PTGS1
463	Hyperplasia	C0020507	5	143	4.226430441e-05	0.0001253044654939107	KLK3,AR,KDM1A,PTGS2,TP53
464	AIDS Dementia Complex	C0001849	3	44	4.26135587346e-05	0.00012557510148849797	PTGS2,TP53,APOE
465	Monocytic leukemia	C0598894	3	44	4.26135587346e-05	0.00012584573748308526	AR,PTGS2,TP53
466	Stomach Diseases	C0038354	3	44	4.26135587346e-05	0.00012611637347767255	PTGS2,TP53,PTGS1
467	Nephrotic Syndrome, Minimal Change	C1704321	3	44	4.26135587346e-05	0.0001263870094722598	ALB,HPX,APOE
468	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	C1140680	21	1967	4.33345621573e-05	0.00012665764546684712	RANBP3,PLAG1,KLK3,CTSL,AR,SERPING1,ALB,PTGS2,AKR1C3,NCOA3,PRSS3,PKN1,TP53,CDCP1,KRT9,APOE,PTGS1,SCAF1,CABLES1,PEG3,RBP4
469	Chronic liver disease	C0341439	5	144	4.3944830974e-05	0.00012692828146143437	ALB,PTGS2,TP53,APOE,RBP4
470	Astrocytoma	C0004114	11	674	4.39856166486e-05	0.00012719891745602166	CST3,AR,GSN,TSC22D1,PTGS2,AKR1C3,NCOA3,H3F3B,GFAP,TP53,APOE
471	Peripheral axonal degeneration	C4025830	4	88	4.48308229932e-05	0.00012746955345060892	TTR,SERPING1,GJC2,SETX
479	Carcinogenesis	C0596263	32	3723	4.55071956439e-05	0.00012963464140730718	PLAG1,KLK3,RBP2,CTSL,CHKB,AR,GSN,SLC1A5,TSC22D1,ALB,DCD,KDM1A,PTGS2,AKR1C3,BBC3,NCOA3,HIST4H4,H3F3B,PKN1,PIK3R3,GFAP,TP53,CAMTA1,PHC3,KCNMA1,AHSG,HPX,APOE,PTGS1,CABLES1,PEG3,RBP4
480	Noninfiltrating Intraductal Carcinoma	C0007124	7	291	4.61374983382e-05	0.00012990527740189446	AR,GSN,PTGS2,AKR1C3,NCOA3,TP53,HPX
481	Drug usage	C0242510	3	45	4.66123074651e-05	0.00013017591339648175	PTGS2,TP53,APOE
482	Pointed chin	C1844505	3	45	4.66123074651e-05	0.000130446549391069	AP4E1,CAMTA1,OBSL1
483	Ganglioglioma	C0206716	3	45	4.66123074651e-05	0.0001307171853856563	AR,GFAP,TP53
484	Hyperlipidemia, combined, 1	C0020473	7	293	4.84152430554e-05	0.00013098782138024358	ALB,HP,SLC25A13,CDCP1,APOE,PTGS1,APOC1
485	Babinski sign	C0034935	5	147	4.93102077783e-05	0.00013125845737483086	SPAST,SACS,AP4E1,GJC2,SETX
486	Overweight	C0497406	6	217	5.14907001572e-05	0.00013152909336941812	AR,PTGS2,TP53,AHSG,APOE,RBP4
492	Abnormality of higher mental function	C4023352	13	920	5.47751667599e-05	0.00013315290933694183	CST3,CHKB,AR,TTR,SPAST,SACS,KDM1A,GJC2,TP53,CAMTA1,SLC25A13,APOE,SETX
493	Drusen	C1260959	3	47	5.54228648761e-05	0.0001334235453315291	ALB,PTGS2,APOE
494	Urinary tract infection	C0042029	4	92	5.54933157445e-05	0.00013369418132611638	PLAG1,KLK3,PTGS2,PTGS1
495	Restenosis	C0333186	6	220	5.61503560613e-05	0.00013396481732070364	SERPING1,ALB,HP,PKN1,TP53,APOE
496	Abnormality of brain morphology	C4021085	18	1573	5.66998616736e-05	0.00013423545331529095	CST3,CHKB,AR,TTR,SACS,KDM1A,CRB1,TRAPPC11,AP4E1,GJC2,GFAP,TP53,CAMTA1,OBSL1,SLC25A13,SCN5A,APOE,SETX
592	Bile duct cancer resectable	C0740277	3	48	6.02563101655e-05	0.00016021650879566982	PTGS2,TP53,APOE
593	Increased antibody level in blood	C0151669	3	48	6.02563101655e-05	0.0001604871447902571	KRT1,KRT9,SETX
594	Pelvic inflammatory disease	C0242172	3	48	6.02563101655e-05	0.00016075778078484436	CST3,SERPING1,PTGS2
595	Poorly differentiated carcinoma	C0741899	3	48	6.02563101655e-05	0.00016102841677943168	AR,PTGS2,TP53
596	Morphological abnormality of the central nervous system	C4021765	19	1722	6.08260139271e-05	0.00016129905277401896	CST3,CHKB,AR,TTR,SPAST,SACS,KDM1A,CRB1,TRAPPC11,AP4E1,GJC2,GFAP,TP53,CAMTA1,OBSL1,SLC25A13,SCN5A,APOE,SETX
597	Cardiac arrest	C0018790	6	223	6.11498244768e-05	0.00016156968876860622	AR,TTR,SPAST,TP53,SCN5A,APOE
598	Paraplegia	C0030486	4	94	6.15089842931e-05	0.0001618403247631935	TTR,SPAST,AP4E1,GJC2
599	Metastatic Prostate Carcinoma	C0936223	6	224	6.28950409152e-05	0.0001621109607577808	KLK3,AR,PTGS2,PRSS3,PKN1,TP53
600	Creutzfeldt-Jakob Syndrome	C0022336	4	95	6.46993236667e-05	0.00016238159675236808	PTGS2,GFAP,APOE,PTGS1
608	Prostate cancer, familial	C2931456	3	49	6.5390012953e-05	0.0001645466847090663	PLAG1,KLK3,AR
609	Multiple tumors	C0260037	4	96	6.80157559386e-05	0.0001648173207036536	AR,PTGS2,GFAP,TP53
610	androgen independent prostate cancer	C1654637	5	156	6.86219162446e-05	0.00016508795669824088	PLAG1,KLK3,AR,PTGS2,TP53
611	Chronic myeloid leukemia	C0023473	12	822	6.99503082882e-05	0.00016535859269282816	CST3,RBP2,CTSL,AR,PTGS2,HP,AKR1C3,NCOA3,HIST4H4,TP53,CDCP1,PTGS1
612	Dyslipidemias	C0242339	6	228	7.02886695776e-05	0.00016562922868741542	AR,PTGS2,HP,AHSG,APOE,RBP4
613	Ovarian Neoplasms	C0919267	13	942	7.05023512515e-05	0.0001658998646820027	PLAG1,KLK3,AR,PTGS2,NCOA3,PKN1,TP53,CDCP1,APOE,PTGS1,SCAF1,CABLES1,PEG3
614	Vascular lesions	C1402315	3	50	7.08351931366e-05	0.00016617050067659	PKN1,TP53,APOE
615	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11	C0026850	7	311	7.34752806818e-05	0.00016644113667117728	CHKB,AR,HP,TRAPPC11,PKN1,TP53,PEG3
616	Prostatic Neoplasms	C0033578	18	1606	7.47708530442e-05	0.00016671177266576454	CST3,PLAG1,KLK3,AR,SLC1A5,DCD,KDM1A,PTGS2,AKR1C3,NCOA3,PRSS3,PKN1,TP53,KCNMA1,CDCP1,HPX,APOE,PEG3
617	Hyperplastic Polyp	C0333983	4	98	7.5040801983e-05	0.00016698240866035182	GSN,PTGS2,TP53,PTGS1
618	Shy-Drager syndrome	C0037019	4	98	7.5040801983e-05	0.00016725304465493914	CST3,TTR,GFAP,APOE
619	Onset	C0206132	11	713	7.52645473572e-05	0.0001675236806495264	CHKB,AR,TTR,GSN,SACS,AP4E1,LDB3,GJC2,GFAP,SCN5A,APOE
620	Anaplasia	C0002793	6	231	7.62877001738e-05	0.00016779431664411368	PLAG1,KLK3,AR,ALB,NCOA3,TP53
621	Malignant neoplasm of female breast	C0235653	3	51	7.66032918293e-05	0.00016806495263870094	KLK3,AR,TP53
622	Bloom syndrome	C0005859	3	51	7.66032918293e-05	0.00016833558863328825	PTGS2,TP53,SCN5A
630	Hemochromatosis	C0018995	4	99	7.87562737065e-05	0.00017050067658998648	ALB,HP,TP53,APOE
631	Steinert myotonic dystrophy syndrome	C0027126	5	160	7.89426123109e-05	0.00017077131258457377	AR,LDB3,SCN5A,APOE,APOC1
632	Abnormality of muscle physiology	C4023182	17	1477	8.14035665422e-05	0.00017104194857916102	CHKB,AR,TTR,GSN,SPAST,SACS,KDM1A,CRB1,TRAPPC11,AP4E1,LDB3,GJC2,GFAP,TP53,CAMTA1,SCN5A,SETX
633	Abnormality of the nervous system	C0497552	24	2512	8.15027726875e-05	0.0001713125845737483	CST3,CHKB,AR,TTR,GSN,SERPING1,SPAST,SACS,KDM1A,CRB1,TRAPPC11,AP4E1,LDB3,GJC2,GFAP,TP53,CAMTA1,OBSL1,SLC25A13,KCNMA1,SCN5A,APOE,SETX,NLRC4
634	Stage 5 chronic kidney disease	C2316810	6	234	8.26985707559e-05	0.0001715832205683356	KLK3,TTR,GSN,ALB,AHSG,APOE
635	Leukoplakia	C0023531	3	52	8.27056826159e-05	0.00017185385656292288	PTGS2,GFAP,TP53
636	Disseminated Malignant Neoplasm	C0346957	5	162	8.4547409956e-05	0.00017212449255751014	AR,PTGS2,PKN1,TP53,KCNMA1
637	Abnormality of the musculature	C4021745	19	1765	8.54475758457e-05	0.00017239512855209743	CHKB,AR,TTR,GSN,SPAST,SACS,KDM1A,CRB1,TRAPPC11,KRT1,AP4E1,LDB3,GJC2,GFAP,TP53,CAMTA1,OBSL1,SCN5A,SETX
638	Drug Resistant Epilepsy	C1096063	3	53	8.91540845864e-05	0.0001726657645466847	ALB,GFAP,APOE
639	Cancer Cell Growth	C1516170	7	320	8.95709304652e-05	0.000172936400541272	KLK3,AR,PTGS2,BBC3,NCOA3,TP53,CDCP1
644	Polymyositis	C0085655	4	102	9.07575003334e-05	0.0001742895805142084	AR,PTGS2,TP53,PTGS1
645	Female Breast Carcinoma	C0007104	3	54	9.59602402167e-05	0.00017456021650879566	KLK3,AR,TP53
646	Progressive myoclonus epilepsy	C0751778	3	54	9.59602402167e-05	0.00017483085250338297	CST3,AR,SACS
647	Lip and Oral Cavity Carcinoma	C0220641	8	419	0.000102955980973	0.00017510148849797023	CTSL,AR,KDM1A,PTGS2,HP,BBC3,PKN1,TP53
648	Neoplasm of the rectum	C0034885	4	105	0.000104117683523	0.0001753721244925575	PTGS2,TP53,AHSG,APOE
649	Diabetes mellitus type 1	C0011854	14	1104	0.000104313939957	0.00017564276048714477	CTSL,AR,TTR,GSN,ALB,PTGS2,HP,PIK3R3,GFAP,TP53,SCN5A,APOE,RBP4,APOC1
655	Thrombocytosis, benign familial microcytic	C0836924	4	106	0.000108890564448	0.00017726657645466848	AR,HP,APOE,PTGS1
656	Benign Prostatic Hyperplasia	C1704272	8	423	0.000110611647479	0.00017753721244925574	PLAG1,KLK3,AR,PTGS2,HP,AKR1C3,TP53,KCNMA1
657	Dyspepsia	C0013395	3	56	0.000110693377974	0.00017780784844384303	PTGS2,TP53,PTGS1
715	Head and Neck Neoplasms	C0018671	7	333	0.000117898802105	0.00019350473612990526	AR,PTGS2,HP,BBC3,TP53,APOE,PTGS1
716	Dysmorphic features	C0432072	3	57	0.000118644480933	0.00019377537212449255	CAMTA1,JARID2,PTGS1
717	Malignant Fibrous Histiocytoma	C0334463	3	57	0.000118644480933	0.00019404600811907986	AR,PTGS2,TP53
718	Neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset	C0030286	3	57	0.000118644480933	0.00019431664411366712	ALB,TP53,SLC25A13
719	Medullary carcinoma	C0206693	3	57	0.000118644480933	0.0001945872801082544	PTGS2,TP53,PTGS1
720	Carcinoma, Small Cell	C0262584	4	108	0.000118938817629	0.00019485791610284167	KLK3,CTSL,AR,TP53
726	Metabolic Syndrome X	C0524620	10	638	0.00012323714167	0.00019648173207036538	AR,TOMM40,ALB,PTGS2,NCOA3,AHSG,APOE,PTGS1,RBP4,APOC1
727	Chorea, childhood-onset, with psychomotor retardation	C0008489	4	109	0.000124221952955	0.00019675236806495264	TRAPPC11,GJC2,KCNMA1,SETX
728	Oropharyngeal squamous cell carcinoma	C0280313	3	58	0.00012700142148	0.00019702300405953992	PTGS2,TP53,PEG3
729	Skin Carcinogenesis	C1519346	4	110	0.000129683162877	0.0001972936400541272	AR,PTGS2,KRT1,TP53
730	Retinopathy	C0035309	8	434	0.000134167139314	0.0001975642760487145	ALB,PTGS2,CRB1,HP,GFAP,TP53,APOE,RBP4
731	Paraplegia/paraparesis	C4023792	4	111	0.000135326458689	0.00019783491204330175	TTR,SPAST,AP4E1,GJC2
732	Retinal detachment	C0035305	4	111	0.000135326458689	0.00019810554803788904	CRB1,HP,GFAP,TP53
733	Carcinoma, Lobular	C0206692	3	59	0.000135776692289	0.00019837618403247632	AR,PTGS2,TP53
734	Oral Submucous Fibrosis	C0029172	3	59	0.000135776692289	0.0001986468200270636	CST3,PTGS2,TP53
735	Desmoid tumor	C0079218	3	59	0.000135776692289	0.00019891745602165087	AR,PTGS2,TP53
738	Inflammation	C0021368	10	647	0.000139263574307	0.00019972936400541272	CST3,SERPING1,PTGS2,HP,PRSS3,TP53,AHSG,APOE,PTGS1,APOC1
739	Oropharyngeal Carcinoma	C2349952	3	60	0.000144982538841	0.0002	BBC3,TP53,PEG3
740	Adverse drug events and drug allergies	C0041755	3	60	0.000144982538841	0.00020027063599458727	ALB,PTGS2,TP53
741	CNS disorder	C0007682	4	113	0.000147175645279	0.00020054127198917458	CST3,TTR,GFAP,APOE
742	Abnormality of the cerebral vasculature	C4022001	5	180	0.00015062874826	0.00020081190798376184	CST3,TTR,TP53,OBSL1,SCN5A
743	Hyperkeratosis	C0870082	6	258	0.000151508459374	0.00020108254397834912	KRT1,LDB3,TP53,SCN5A,KRT9,APOC1
744	Malignant tumor of cervix	C0007847	12	889	0.000152540596853	0.00020135317997293638	CTSL,AR,GSN,SLC1A5,TSC22D1,PTGS2,AKR1C3,BBC3,TP53,PTGS1,PEG3,RBP4
745	Cognitive Dysfunction	C0338656	11	769	0.000152834762707	0.0002016238159675237	CST3,TTR,TOMM40,SPAST,ALB,PTGS2,GJC2,TP53,APOE,JARID2,APOC1
746	Pancreatic intraepithelial neoplasia	C1301034	3	61	0.000154631588168	0.00020189445196211095	PTGS2,NCOA3,TP53
747	Colonic Polyps	C0009376	3	61	0.000154631588168	0.00020216508795669824	PTGS2,TP53,PTGS1
751	Dermatomyositis	C0011633	4	115	0.000159802665105	0.00020324763193504735	CTSL,PTGS2,TP53,PTGS1
752	Synovial Cyst	C0085648	5	182	0.000159961195803	0.00020351826792963467	PTGS2,GFAP,TP53,SCN5A,APOE
753	Tremor, hereditary essential, 5	C0040822	7	349	0.000162559887114	0.00020378890392422193	AR,TTR,TRAPPC11,GJC2,GFAP,APOE,SETX
754	Esophagitis	C0014868	3	62	0.00016473641335	0.0002040595399188092	PTGS2,TP53,PTGS1
755	Spastic paraplegia 9	C0037772	4	116	0.000166418493817	0.00020433017591339647	SPAST,AP4E1,GJC2,GFAP
756	Squamous cell carcinoma	C0007137	19	1855	0.000167441432998	0.00020460081190798378	CTSL,AR,GSN,SLC1A5,PTGS2,HP,AKR1C3,KRT1,BBC3,NCOA3,HIST4H4,PKN1,GFAP,TP53,CDCP1,KRT9,APOE,PTGS1,CLCA2
757	Carcinoma of colon	C0699790	19	1856	0.000168650543633	0.00020487144790257104	RANBP3,AR,GSN,ALB,KDM1A,PTGS2,BBC3,NCOA3,PKN1,TP53,CTAGE5,CDCP1,AHSG,SCN5A,APOE,JARID2,PTGS1,SCAF1,CABLES1
758	Nephrotic syndrome, type 5, with or without ocular abnormalities	C0027726	6	263	0.000170469885358	0.00020514208389715833	CTSL,GSN,ALB,PTGS2,HPX,APOE
759	Abnormality of cardiovascular system electrophysiology	C0243050	17	1568	0.000172317391098	0.0002054127198917456	CST3,CHKB,TTR,GSN,SERPING1,ALB,CRB1,KRT1,LDB3,TP53,OBSL1,SCN5A,KRT9,APOE,SETX,RBP4,NLRC4
760	Sensory neuropathy	C0151313	5	185	0.000174811752451	0.0002056833558863329	AR,GJC2,TP53,APOE,NLRC4
761	Microsatellite Instability	C0796369	3	63	0.000175309720001	0.00020595399188092018	AR,TP53,APOE
762	Cardiovascular Diseases	C0007222	13	1029	0.000177868331538	0.00020622462787550744	CST3,TOMM40,ALB,PTGS2,HP,PKN1,TP53,AHSG,SCN5A,APOE,PTGS1,RBP4,APOC1
763	Bulbar palsy	C0030442	2	25	0.000179368228126	0.00020649526387009473	AR,GSN
764	Chromosome 11p deletion syndrome	C0812435	2	25	0.000179368228126	0.000206765899864682	AR,SLC22A6
765	Meningioma	C0025286	8	452	0.000181715482388	0.0002070365358592693	CST3,CTSL,AR,TTR,PTGS2,GFAP,TP53,CTAGE5
766	Ovarian epithelial cancer	C0677886	21	2172	0.000185002451922	0.00020730717185385656	RANBP3,PLAG1,KLK3,CTSL,AR,GSN,ALB,PTGS2,HP,NCOA3,PRSS3,PKN1,TP53,CDCP1,KRT9,APOE,PTGS1,SCAF1,CABLES1,PEG3,RBP4
767	Breast Fibrocystic Disease	C0016034	3	64	0.000186364287893	0.00020757780784844384	AR,PTGS2,TP53
768	Early-Stage Breast Carcinoma	C2986665	3	64	0.000186364287893	0.00020784844384303113	PTGS2,TP53,APOE
769	Vascular inflammations	C0947751	4	119	0.000187526788661	0.0002081190798376184	CST3,PTGS2,APOE,RBP4
842	Colon cancer	C0007102	18	1727	0.000192700276922	0.00022787550744248985	RANBP3,AR,GSN,ALB,KDM1A,PTGS2,BBC3,NCOA3,PKN1,TP53,CDCP1,AHSG,SCN5A,APOE,JARID2,PTGS1,SCAF1,CABLES1
843	Lipomatosis, Multiple	C3489413	2	26	0.000202113301099	0.00022814614343707714	PLAG1,TP53
844	Malignant neoplasm of adrenal cortex	C0346402	2	26	0.000202113301099	0.00022841677943166442	ALB,TP53
845	Lymphoid hyperplasia	C0333997	2	26	0.000202113301099	0.00022868741542625168	AR,TP53
846	Oropharynx (excludes nasopharynx)	C0521367	2	26	0.000202113301099	0.00022895805142083897	SERPING1,TP53
847	Ependymoma	C0014474	4	121	0.000202693749592	0.00022922868741542628	TTR,PTGS2,GFAP,TP53
848	Carcinoma of cervix	C0302592	13	1045	0.000208433846797	0.00022949932341001354	CTSL,AR,GSN,SLC1A5,TSC22D1,PTGS2,HP,AKR1C3,BBC3,TP53,PTGS1,PEG3,RBP4
849	Unspecified visual loss	C3665346	3	66	0.000209968932657	0.00022976995940460082	TTR,CRB1,RBP4
850	Non-Neoplastic Disorder	C1709246	8	461	0.000210313928603	0.00023004059539918808	CTSL,AR,ALB,KDM1A,PTGS2,AKR1C3,TP53,CAMTA1
851	Malnutrition	C0162429	4	122	0.000210619021152	0.0002303112313937754	TTR,ALB,AHSG,APOE
852	Renal Insufficiency, Chronic	C0035078	7	363	0.000212297345443	0.00023058186738836265	CST3,KLK3,ALB,HP,SLC22A6,TP53,APOE
853	Epilepsy, Temporal Lobe	C0014556	5	192	0.00021371625964	0.00023085250338294994	SPAST,PTGS2,TP53,APOE,TLN2
854	aggressive cancer	C2945759	3	67	0.000222545051841	0.0002311231393775372	KLK3,PTGS2,TP53
855	Macular Degeneration	C0024437	5	194	0.000225999080848	0.0002313937753721245	CST3,SERPING1,CRB1,APOE,APOC1
856	Abnormality of male internal genitalia	C4025899	2	27	0.000226647789691	0.00023166441136671177	AR,TP53
857	Left ventricular noncompaction	C1960469	2	27	0.000226647789691	0.00023193504736129905	LDB3,SCN5A
858	Peeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads	C0237849	2	27	0.000226647789691	0.00023220568335588634	KRT1,APOC1
859	Seborrheic keratosis	C0022603	2	27	0.000226647789691	0.00023247631935047363	AR,TP53
860	Myoepithelioma	C0027070	2	27	0.000226647789691	0.0002327469553450609	PLAG1,GFAP
861	Heart Failure	C0018801	11	803	0.00022752077169	0.00023301759133964817	CST3,TTR,GSN,ALB,PTGS2,HP,TP53,SCN5A,APOE,JARID2,PTGS1
